No Evidence of Post-Finasteride Syndrome in 267,983 Person-Years Follow-up in the Prostate Cancer Prevention Trial.

Till C, Tangen CM, Goodman P, Unger JM, Thompson IM Jr

Open source

DOI
10.1016/j.urology.2026.08.020
Published
2026 Aug 22
Container
Urology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.urology.2026.08.020,
  title = {No Evidence of Post-Finasteride Syndrome in 267,983 Person-Years Follow-up in the Prostate Cancer Prevention Trial.},
  author = {Till C and Tangen CM and Goodman P and Unger JM and Thompson IM Jr},
  year = {2026},
  journal = {Urology},
  doi = {10.1016/j.urology.2026.08.020},
  url = {https://doi.org/10.1016/j.urology.2026.08.020}
}

RIS

TY  - JOUR
TI  - No Evidence of Post-Finasteride Syndrome in 267,983 Person-Years Follow-up in the Prostate Cancer Prevention Trial.
AU  - Till C
AU  - Tangen CM
AU  - Goodman P
AU  - Unger JM
AU  - Thompson IM Jr
PY  - 2026
JO  - Urology
DO  - 10.1016/j.urology.2026.08.020
UR  - https://doi.org/10.1016/j.urology.2026.08.020
ER  - 

APA

C, T., CM, T., P, G., JM, U., & Jr, T. I. (2026). No Evidence of Post-Finasteride Syndrome in 267,983 Person-Years Follow-up in the Prostate Cancer Prevention Trial.. Urology. https://doi.org/10.1016/j.urology.2026.08.020

Source records